SE9904850D0 - Novel process and intermediates - Google Patents

Novel process and intermediates

Info

Publication number
SE9904850D0
SE9904850D0 SE9904850A SE9904850A SE9904850D0 SE 9904850 D0 SE9904850 D0 SE 9904850D0 SE 9904850 A SE9904850 A SE 9904850A SE 9904850 A SE9904850 A SE 9904850A SE 9904850 D0 SE9904850 D0 SE 9904850D0
Authority
SE
Sweden
Prior art keywords
compound
formula
intermediates
novel process
chem
Prior art date
Application number
SE9904850A
Other languages
English (en)
Swedish (sv)
Inventor
Pehr G Andersson
Christian Hedberg
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9904850A priority Critical patent/SE9904850D0/xx
Publication of SE9904850D0 publication Critical patent/SE9904850D0/xx
Priority to MYPI20005976A priority patent/MY118906A/en
Priority to CA002392832A priority patent/CA2392832A1/fr
Priority to EEP200200325A priority patent/EE200200325A/xx
Priority to CZ20022255A priority patent/CZ20022255A3/cs
Priority to AT00990151T priority patent/ATE282019T1/de
Priority to HU0203816A priority patent/HUP0203816A3/hu
Priority to EP04014454A priority patent/EP1496045A3/fr
Priority to PCT/SE2000/002662 priority patent/WO2001049649A1/fr
Priority to ES00990151T priority patent/ES2228658T3/es
Priority to PL00355947A priority patent/PL355947A1/xx
Priority to EP00990151A priority patent/EP1242361B1/fr
Priority to SK939-2002A priority patent/SK9392002A3/sk
Priority to DE60015799T priority patent/DE60015799T2/de
Priority to PT00990151T priority patent/PT1242361E/pt
Priority to BR0016785-1A priority patent/BR0016785A/pt
Priority to DK00990151T priority patent/DK1242361T3/da
Priority to JP2001550189A priority patent/JP2003519207A/ja
Priority to CNB008180067A priority patent/CN1209342C/zh
Priority to MXPA02006415A priority patent/MXPA02006415A/es
Priority to US09/748,042 priority patent/US6310248B2/en
Priority to AU27190/01A priority patent/AU782796B2/en
Priority to NZ519079A priority patent/NZ519079A/en
Priority to IL15027500A priority patent/IL150275A0/xx
Priority to KR1020027008466A priority patent/KR20020062669A/ko
Priority to PE2000001404A priority patent/PE20011123A1/es
Priority to TW089128081A priority patent/TWI225476B/zh
Priority to ARP000106999A priority patent/AR027138A1/es
Priority to US09/919,401 priority patent/US6566537B2/en
Priority to ZA200204066A priority patent/ZA200204066B/en
Priority to NO20023189A priority patent/NO20023189L/no
Priority to US10/402,671 priority patent/US6790998B2/en
Priority to US10/401,361 priority patent/US6689916B2/en
Priority to HK03104266A priority patent/HK1052000A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/512—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being a free hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9904850A 1999-12-30 1999-12-30 Novel process and intermediates SE9904850D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9904850A SE9904850D0 (sv) 1999-12-30 1999-12-30 Novel process and intermediates
MYPI20005976A MY118906A (en) 1999-12-30 2000-12-20 Novel process and intermediates
KR1020027008466A KR20020062669A (ko) 1999-12-30 2000-12-22 톨테로딘 및 이의 유사체의 제조 방법, 및 이 방법에서제조되는 중간체
DK00990151T DK1242361T3 (da) 1999-12-30 2000-12-22 Fremgangsmåde til fremstilling af tolterodin og analoger deraf såvel som mellemprodukter fremstillet i fremgangsmåden
JP2001550189A JP2003519207A (ja) 1999-12-30 2000-12-22 トルテロジンおよびその類似体の調製方法ならびにこの方法で調製される中間体
CZ20022255A CZ20022255A3 (cs) 1999-12-30 2000-12-22 Způsob přípravy tolterodinu a jeho analogů a meziprodukty připravené při tomto způsobu
AT00990151T ATE282019T1 (de) 1999-12-30 2000-12-22 Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte
HU0203816A HUP0203816A3 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues there of as well as intermediates
EP04014454A EP1496045A3 (fr) 1999-12-30 2000-12-22 Procédé pour la synthèse de tolterodine et de ses analogues et intermédiares
PCT/SE2000/002662 WO2001049649A1 (fr) 1999-12-30 2000-12-22 Procede permettant de preparer de la tolterodine et ses analogues, et produits intermediaires prepares dans ce procede
ES00990151T ES2228658T3 (es) 1999-12-30 2000-12-22 Procedimiento de preparacion de tolterodina y sus analogos, asi como los compuestos intermedios preparados en el procedimiento.
PL00355947A PL355947A1 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
EP00990151A EP1242361B1 (fr) 1999-12-30 2000-12-22 Procede permettant de preparer de la tolterodine et ses analogues, et produits intermediaires prepares dans ce procede
SK939-2002A SK9392002A3 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
DE60015799T DE60015799T2 (de) 1999-12-30 2000-12-22 Verfahren für die herstellung von tolterodine und deren analoga sowie im verfahren hergestellte zwischenprodukte
PT00990151T PT1242361E (pt) 1999-12-30 2000-12-22 Processo de preparacao da tolterodina e seus analogos assim como intermediarios preparados no processo
BR0016785-1A BR0016785A (pt) 1999-12-30 2000-12-22 Processo para a preparação de tolterodina e análogos desta; bem como intermediários obtidos no processo
CA002392832A CA2392832A1 (fr) 1999-12-30 2000-12-22 Procede permettant de preparer de la tolterodine et ses analogues, et produits intermediaires prepares dans ce procede
EEP200200325A EE200200325A (et) 1999-12-30 2000-12-22 Tolterodiini ja selle analoogide valmistamismeetod ning selle meetodi käigus valmistatavad vaheühendid
CNB008180067A CN1209342C (zh) 1999-12-30 2000-12-22 制备托特罗定及其类似物的方法以及在该方法中制备的中间体
MXPA02006415A MXPA02006415A (es) 1999-12-30 2000-12-22 Procedimiento para preparar tolterodina y analogos de la misma asi como los intermediarios preparados en el procedimiento.
US09/748,042 US6310248B2 (en) 1999-12-30 2000-12-22 Process and intermediates
AU27190/01A AU782796B2 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
NZ519079A NZ519079A (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues and intermediates prepared in the process
IL15027500A IL150275A0 (en) 1999-12-30 2000-12-22 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
PE2000001404A PE20011123A1 (es) 1999-12-30 2000-12-27 Proceso para preparar tolterodina y sus intermediarios
TW089128081A TWI225476B (en) 1999-12-30 2000-12-28 Novel process of preparing tolterodine and analogues thereof, and novel intermediates prepared therein
ARP000106999A AR027138A1 (es) 1999-12-30 2000-12-28 Proceso e intermediarios novedosos.
US09/919,401 US6566537B2 (en) 1999-12-30 2001-07-31 Process and intermediates
ZA200204066A ZA200204066B (en) 1999-12-30 2002-05-22 Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process.
NO20023189A NO20023189L (no) 1999-12-30 2002-07-01 Fremgangsmåte for fremstilling av tolterodin og analoger derav samt intermediater fremstilt ved fremgangsmåten
US10/402,671 US6790998B2 (en) 1999-12-30 2003-03-28 Phenyl inden-1-one compounds
US10/401,361 US6689916B2 (en) 1999-12-30 2003-03-28 Phenyl propenone compounds
HK03104266A HK1052000A1 (en) 1999-12-30 2003-06-16 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904850A SE9904850D0 (sv) 1999-12-30 1999-12-30 Novel process and intermediates

Publications (1)

Publication Number Publication Date
SE9904850D0 true SE9904850D0 (sv) 1999-12-30

Family

ID=20418365

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904850A SE9904850D0 (sv) 1999-12-30 1999-12-30 Novel process and intermediates

Country Status (30)

Country Link
US (1) US6310248B2 (fr)
EP (2) EP1496045A3 (fr)
JP (1) JP2003519207A (fr)
KR (1) KR20020062669A (fr)
CN (1) CN1209342C (fr)
AR (1) AR027138A1 (fr)
AT (1) ATE282019T1 (fr)
AU (1) AU782796B2 (fr)
BR (1) BR0016785A (fr)
CA (1) CA2392832A1 (fr)
CZ (1) CZ20022255A3 (fr)
DE (1) DE60015799T2 (fr)
DK (1) DK1242361T3 (fr)
EE (1) EE200200325A (fr)
ES (1) ES2228658T3 (fr)
HK (1) HK1052000A1 (fr)
HU (1) HUP0203816A3 (fr)
IL (1) IL150275A0 (fr)
MX (1) MXPA02006415A (fr)
MY (1) MY118906A (fr)
NO (1) NO20023189L (fr)
NZ (1) NZ519079A (fr)
PE (1) PE20011123A1 (fr)
PL (1) PL355947A1 (fr)
PT (1) PT1242361E (fr)
SE (1) SE9904850D0 (fr)
SK (1) SK9392002A3 (fr)
TW (1) TWI225476B (fr)
WO (1) WO2001049649A1 (fr)
ZA (1) ZA200204066B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (fr) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Dérivés de 3,3-diphénylpropylamines
US6703504B2 (en) 2002-02-11 2004-03-09 Clarke Slemon Conformationally constrained compounds as dendrimer cores
WO2003064501A1 (fr) * 2002-01-31 2003-08-07 Clarke Slemon Composes de conformation restreinte sous forme de coeurs dendrimeres
EP1424079A1 (fr) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
ITMI20031354A1 (it) * 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
ITMI20040616A1 (it) * 2004-03-30 2004-06-30 Dinamite Dipharma S P A In For Processo per la preparazione di tolterodina e suoi intermedi
EP1629834A1 (fr) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Composition pharmaceutique de tolterodine avec liberation soutenue
ITMI20041920A1 (it) * 2004-10-11 2005-01-11 Chemi Spa Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
JP4513535B2 (ja) * 2004-12-03 2010-07-28 住友化学株式会社 トルテロジンの製造方法
CA2592450C (fr) * 2004-12-24 2013-09-03 Lek Pharmaceuticals D.D. Procede de preparation de 3-(2-hydroxy-5-methylphenyl)-n,n-diisopropyl-3-phenylpropylamine
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
ES2268987B1 (es) 2005-08-05 2008-02-01 Ragactives, S.L. Procedimiento para la obtencion de 3,3-difenilpropilaminas.
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
KR100686351B1 (ko) * 2006-01-12 2007-02-22 주식회사 카이로제닉스 톨테로딘 라세미체의 제조방법
DK2029567T3 (da) 2006-05-24 2010-11-29 Pfizer Ltd Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
KR101488740B1 (ko) 2006-06-12 2015-02-03 유씨비 파마 게엠베하 새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그키랄 중간체의 사용
KR100717361B1 (ko) * 2006-08-07 2007-05-11 주식회사 카이로제닉스 톨테로딘 라세미체 및 이의 중간체의 제조방법
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
EP2334378B1 (fr) 2008-08-19 2014-04-09 XenoPort, Inc. Prodrogues du fumarate de mono-méthyle, compositions pharmaceutiques à base de celles-ci, et procédés d'utilisation
CA2748250A1 (fr) 2008-12-24 2010-07-01 Daiichi Sankyo Company, Limited Composes indanyle
CN102307852B (zh) 2008-12-24 2013-12-18 第一三共株式会社 环状胺化合物
KR101275984B1 (ko) * 2010-10-18 2013-06-18 경기대학교 산학협력단 광학활성을 갖는 크로만계 유도체 및 이의 제조방법
DK2639216T3 (en) * 2010-11-09 2018-09-24 Kaneka Corp Halogenated Indones and Methods for Preparation of Optically Active Indanones or Optically Active Indanols Using These
WO2012098044A1 (fr) 2011-01-17 2012-07-26 Cambrex Profarmaco Milano S.R.L. Procédé pour la préparation de n,n-diisopropyl-3-(2-hydroxy-5-méthylphényl)-3-phénylpropylamine et de ses sels à partir d'un nouvel intermédiaire
EP2476665A1 (fr) 2011-01-17 2012-07-18 Cambrex Profarmaco Milano S.r.l. Procédé pour la préparation de N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine et ses sels démarrant à partir d'un nouvel intermédiaire
CN103159657B (zh) * 2011-12-08 2016-06-29 重庆华邦胜凯制药有限公司 一种定向合成不饱和共轭醇的方法
AR094054A1 (es) * 2012-12-19 2015-07-08 H Lundbeck As 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma
KR101380982B1 (ko) 2013-04-29 2014-04-10 경기대학교 산학협력단 광학활성을 갖는 크로만-2-올 유도체 및 이의 제조방법
WO2017137955A1 (fr) 2016-02-14 2017-08-17 Celestis Pharmaceuticals Pvt. Ltd. Nouveau (r) et 3-(2-(allyloxy)-5-méthylphényl)-n,n-diisopropyl-3- phénylpropan-1-amine racémique et son utilisation pour la synthèse de (r) et de 2-(3- (diisopropylamino)-1-phénylpropyl)-4-(hydroxyméthyl)phénol racémique
WO2018013739A2 (fr) * 2016-07-12 2018-01-18 Chromocell Corporation Composés, compositions et procédés de modulation de saveur sucrée
US11535600B2 (en) 2018-12-03 2022-12-27 H. Lundbeck A/S Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d3)piperazine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
ZA969363B (en) 1995-11-08 1997-11-18 Smithkline Beecham Corp An improved process for preparing aromatic ring-fused cyclopentane derivatives.
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
EP0957073A1 (fr) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Dérivés de 3,3-diphénylpropylamines

Also Published As

Publication number Publication date
EP1496045A3 (fr) 2005-03-30
JP2003519207A (ja) 2003-06-17
HK1052000A1 (en) 2003-08-29
MXPA02006415A (es) 2002-11-29
NO20023189L (no) 2002-07-04
SK9392002A3 (en) 2003-01-09
US6310248B2 (en) 2001-10-30
HUP0203816A3 (en) 2004-12-28
EP1242361B1 (fr) 2004-11-10
MY118906A (en) 2005-02-28
ES2228658T3 (es) 2005-04-16
ZA200204066B (en) 2003-07-30
DE60015799T2 (de) 2005-12-15
IL150275A0 (en) 2002-12-01
CA2392832A1 (fr) 2001-07-12
ATE282019T1 (de) 2004-11-15
DE60015799D1 (de) 2004-12-16
KR20020062669A (ko) 2002-07-26
WO2001049649A1 (fr) 2001-07-12
AU782796B2 (en) 2005-09-01
DK1242361T3 (da) 2005-02-14
HUP0203816A2 (hu) 2003-03-28
NZ519079A (en) 2004-02-27
CN1209342C (zh) 2005-07-06
AU2719001A (en) 2001-07-16
TWI225476B (en) 2004-12-21
AR027138A1 (es) 2003-03-12
PT1242361E (pt) 2005-01-31
NO20023189D0 (no) 2002-07-01
US20010016669A1 (en) 2001-08-23
CN1414944A (zh) 2003-04-30
BR0016785A (pt) 2002-09-24
EP1242361A1 (fr) 2002-09-25
PE20011123A1 (es) 2001-11-09
EE200200325A (et) 2003-08-15
EP1496045A2 (fr) 2005-01-12
CZ20022255A3 (cs) 2002-11-13
PL355947A1 (en) 2004-05-31

Similar Documents

Publication Publication Date Title
SE9904850D0 (sv) Novel process and intermediates
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
AU2001252595A1 (en) Process for producing optically active sulfoxide derivative
ATE452882T1 (de) Herstellung von quetiapin
UA106191C2 (ru) Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина
WO2008126943A3 (fr) Procédé de fabrication de dérivés de l'acide neuraminique
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
EP1555261A4 (fr) Composes de valerolactone et composition de parfum
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
WO2005058812A3 (fr) Synthese de la prostaglandine
DE60006857D1 (de) Verfahren zur herstellung von pyridinmethanol-verbindungen
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
HUP0003857A2 (hu) Eljárás alkoxi-furanon-amin-származékok előállítására, az eljárással kapott vegyületek és a vegyületek alkalmazása
PT786459E (pt) Processo para a preparacao de um enantiomero de alcool heterobiciclico
RS20050937A (en) Resolution of alpha- (phenoxy)phenylacetic acid derivatives
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
IL180571A0 (en) Method for producing enantiomeric from of 2,3-diaminopropionic acid derivatives
EE05326B1 (et) D-vitamiini prekursorid, meetod ja vahehendid
EP1698617A4 (fr) Procede de production d'un compose de cycloalkylidene et de bisoxazoline optiquement actif et ses intermediaires
TW200503701A (en) Novel intermediate for the preparation of therapeutically active imidazopyridines
ATE440098T1 (de) Enantiomerenreine hexahydropyrrolocyclopentapyridin-derivate
WO2008140328A3 (fr) Nouveaux intermédiaires, leur procédé de préparation et synthèse de 1,4-benzoquinones